The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Alzheimer's β-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40
Abstract
Accumulating evidence suggests that beta-amyloid (Abeta)-induced inflammatory reactions may partially drive the pathogenesis of Alzheimer's disease (AD). Recent data also implicate similar inflammatory processes in cerebral amyloid angiopathy (CAA). To evaluate the roles of Abeta in the inflammatory processes in vascular tissues, we have tested the ability of Abeta to trigger inflammatory responses in cultured human vascular cells. We found that stimulation with Abeta dose-dependently increased the expression of CD40, and secretion of interferon-gamma (IFN-gamma) and interleukin-1beta (IL-1beta) in endothelial cells. Abeta also induced expression of IFN-gamma receptor (IFN-gammaR) both in endothelial and smooth muscle cells. Characterization of the Abeta-induced inflammatory responses in the vascular cells showed that the ligation of CD40 further increased cytokine production and/or the expression of IFN-gammaR. Moreover, IL-1beta and IFN-gamma synergistically increased the Abeta-induced expression of CD40 and IFN-gammaR. We have recently found that Abeta induces expression of adhesion molecules, and that cytokine production and interaction of CD40-CD40 ligand (CD40L) further increase the Abeta-induced expression of adhesion molecules in these same cells. These results suggest that Abeta can function as an inflammatory stimulator to activate vascular cells and induces an auto-amplified inflammatory molecular cascade, through interactions among adhesion molecules, CD40-CD40L and cytokines. Additionally, Abeta1-42, the more pathologic form of Abeta, induces much stronger effects in endothelial cells than in smooth muscle cells, while the reverse is true for Abeta1-40. Collectively, these findings support the hypothesis that the Abeta-induced inflammatory responses in vascular cells may play a significant role in the pathogenesis of CAA and AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In vitro treatment of endothelial cells with Aβ induced expression of multiple inflammatory molecules, including IFN-γ, IL-6, IL-1β, and CD40,470,471 increasing the secretion of monocyte chemoattractant, MCP-1, which has been shown to be highly expressed in the cerebral endothelial cells from AD patients.471”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [470]
Citations
Cites
MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287
Blum-Degena, D., Müller, T., Kuhn, W., Gerlach, M., Przuntek, H., & Riederer, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12192-7 · Cited by 801
Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells.
Goldgaber, D., Harris, H. W., Hla, T., Maciag, T., DONNELLY, R. J., Jacobsen, J. S., Vitek, M. P., & Gajdusek, D. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7606 · Cited by 597
Mach, F., Schönbeck, U., Bonnefoy, J., Pober, J. S., & Libby, P. (1997) · Circulation · doi:10.1161/01.cir.96.2.396 · Cited by 493
CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis.
Gerritse, K., Laman, J. D., Noelle, R. J., Aruffo, A. A., Ledbetter, J. A., Boersma, W. J., & Claassen, E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2499 · Cited by 484
Geng, Y., Wu, Q. Y., Muszynski, M., Hansson, G. K., & Libby, P. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.1.19 · Cited by 432
Cytokines Regulate Vascular Functions Related to Stability of the Atherosclerotic Plaque
Libby, P., Sukhova, G. K., Lee, R. T., & Galis, Z. S. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199500252-00003 · Cited by 371
Schönbeck, U., Mach, F., Sukhova, G. K., Murphy, C., Bonnefoy, J., Fabunmi, R. P., & Libby, P. (1997) · Circulation Research · doi:10.1161/01.res.81.3.448 · Cited by 334
Geng, Y., Henderson, L. E., Levesque, E. B., Muszynski, M., & Libby, P. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.2200 · Cited by 266
Vandenabeele, P., & Fiers, W. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90032-o · Cited by 265
Research works printed but not linked: 1
- M. Tewari, V.M. Dixit, Signalling through members of the tumor necrosis factor receptor family, in: C.H. Heldin, M. Purton (Eds.), Signal Transduction, Chapman & Hall, London, 1996, pp. 79–92.
Cited by
Sorted by citations
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668
Gene-expression profile of the ageing brain in mice
Lee, C.-K., Weindruch, R., & Prolla, T. A. (2000) · Nature Genetics · doi:10.1038/77046 · Cited by 1,055
Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease
Cai, Z., Hussain, M. D., & Yan, L.-J. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2013.833510 · Cited by 583
Neurodegenerative disorders: the role of peroxynitrite
Torreilles, F., Salman-Tabcheh, S., Guérin, M.-C., & Torreilles, J. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00014-4 · Cited by 430
Grammas, P. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-26 · Cited by 432
Scolding, N. J. (2005) · Brain · doi:10.1093/brain/awh379 · Cited by 372
Inflammatory factors are elevated in brain microvessels in Alzheimer's disease
Grammas, P. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00276-7 · Cited by 298
Govindpani, K., McNamara, L. G., Smith, N. R., Vinnakota, C., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050651 · Cited by 281
Marco, L. Y. D., Venneri, A., Farkas, E., Evans, P. C., Marzo, A., & Frangi, A. F. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.014 · Cited by 260
Expression of interleukin-18 is increased in the brains of Alzheimer’s disease patients
Ojala, J., Alafuzoff, I., Herukka, S.-K., van Groen, T., Tanila, H., & Pirttilä, T. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.006 · Cited by 235
Vukic, V., Callaghan, D., Walker, D., Lue, L.-F., Liu, Q. Y., Couraud, P.-O., Romero, I. A., Weksler, B., Stanimirovic, D. B., & Zhang, W. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.12.007 · Cited by 232
T-helper-1 and T-helper-2 Responses in Psychiatric Disorders
Schwarz, M., Chiang, S. S. W., Müller, N., & Ackenheil, M. (2001) · Brain Behavior and Immunity · doi:10.1006/brbi.2001.0647 · Cited by 222
Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease
Farfara, D., Lifshitz, V., & Frenkel, D. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00314.x · Cited by 216
Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors.
(2014) · Europe PMC (PubMed Central) · Cited by 177
Rossi, B., Angiari, S., Zenaro, E., Budui, S. L., & Constantin, G. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0710432 · Cited by 172
Gene expression profiling of aging using DNA microarrays
Weindruch, R. H., Kayo, T., Lee, C., & Prolla, T. A. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00344-x · Cited by 171
Inflammatory Proteins in Plasma Are Associated with Severity of Alzheimer’s Disease
Leung, R., Proitsi, P., Simmons, A., Lunnon, K., Güntert, A., Kronenberg, D., Pritchard, M., Tsolaki, M., Mecocci, P., Kloszewska, I., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064971 · Cited by 160
Flavonoid‐mediated presenilin‐1 phosphorylation reduces Alzheimer's disease β‐amyloid production
Rezai-Zadeh, K. P., Shytle, R. D., Bai, Y., Tian, J., Hou, H., Mori, T., Zeng, J., Obregon, D. F., Town, T., & Tan, J. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00344.x · Cited by 155
Self-citationMacManus, A., Ramsden, M., Murray, M., Henderson, Z., Pearson, H. A., & Campbell, V. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.4713 · Cited by 137
Grammas, P., & Ovase, R. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61105-4 · Cited by 133
Expression of CD40 in the brain of Alzheimer’s disease and other neurological diseases
Togo, T., Akiyama, H., Kondo, H., Ikeda, K., Kato, M., Iseki, E., & Kosaka, K. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02984-x · Cited by 131
Alzheimer disease and platelets: how’s that relevant
Catricalà, S., Torti, M., & Ricevuti, G. (2012) · Immunity & Ageing · doi:10.1186/1742-4933-9-20 · Cited by 132
IL‐4 attenuates the neuroinflammation induced by amyloid‐β in vivo and in vitro
Lyons, A., Griffin, R. J., Costelloe, C., Clarke, R. M., & Lynch, M. A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04370.x · Cited by 129
Nikolic, W. V., Hou, H., Town, T., Zhu, Y., Giunta, B. N., Sanberg, C. D., Zeng, J., Luo, D., Ehrhart, J. C., Mori, T., et al. (2008) · Stem Cells and Development · doi:10.1089/scd.2008.0018 · Cited by 114
Self-citationCalingasan, N. Y., Erdely, H. A., & Altar, C. A. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00246-9 · Cited by 109
Lee, Y. W., Cho, H. J., Lee, W. H., & Sonntag, W. E. (2012) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2012.20.4.357 · Cited by 103
Hu, J., & Eldik, L. J. V. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01804-1 · Cited by 101
Grammer, A. C., & Lipsky, P. E. (2001) · Advances in immunology · doi:10.1016/s0065-2776(01)76019-1 · Cited by 100
Protective effects of S-nitrosoglutathione against amyloid β-peptide neurotoxicity
Ju, T., Chen, S., Liu, C.-C., & Yang, D. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.12.019 · Cited by 96
Minogue, A. M., Lynch, A. M., Loane, D. J., Herron, C. E., & Lynch, M. A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04848.x · Cited by 100
Askarova, S., Yang, X., Sheng, W., Sun, G. Y., & Lee, J. C.-M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.038 · Cited by 92
Sawmiller, D. R., Habib, A., Li, S., Darlington, D., Hou, H., Tian, J., Shytle, R. D., de Smith, A. J., Giunta, B. N., Mori, T., et al. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.08.018 · Cited by 92
Self-citationChanges in the immune system in depression and dementia: causal or co‐incidental effects?
Leonard, B. E. (2001) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(01)00014-4 · Cited by 91
Soluble adhesion molecules and angiotensin-converting enzyme in dementia
Nielsen, H. M., Londos, E., Minthon, L., & Janciauskiene, S. M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.11.011 · Cited by 80
Mocali, A., Cedrola, S., Malva, N. D., Bontempelli, M., Costanza, V. A. M., Bavazzano, A., Comolli, R., Paoletti, F., & Porta, C. A. M. L. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.07.007 · Cited by 79
Ramin, M., Azizi, P., Motamedi, F., Haghparast, A., & Khodagholi, F. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.017 · Cited by 71
Lee, Y. W., & Lee, W. H. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.10.006 · Cited by 66
Gonzalez‐Velasquez, F. J., Kotarek, J. A., & Moss, M. A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05618.x · Cited by 67
Cerebral amyloid angiopathy-related inflammation: imaging findings and clinical outcome
Martucci, M., Sarria‐Estrada, S., Toledo, M., Coscojuela, P., Vert, C., Siurana, S., Auger, C., & Rovira, À. (2014) · Neuroradiology · doi:10.1007/s00234-014-1330-6 · Cited by 66
CD40 signaling and Alzheimer's disease pathogenesis
Town, T., Tan, J., & MULLAN, M. J. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00044-4 · Cited by 61
Self-citationMiao, J., Vitek, M. P., Xu, F., Previti, M. L., Davis, J., & Nostrand, W. E. V. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1306-05.2005 · Cited by 64
Suppressor of Cytokine Signaling 1 Inhibits Cytokine Induction of CD40 Expression in Macrophages
Wesemann, D. R., Dong, Y., O'Keefe, G. M., Nguyen, V. T., & Benveniste, E. N. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2354 · Cited by 64
Chatterjee, P., Goozee, K. G., Lim, C. K., JAMES, I. R., Shen, K., Jacobs, K. R., Sohrabi, H. R., Shah, T. M., Asih, P. R., Dave, P., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25968-7 · Cited by 60
Kokjohn, T. A., Vickle, G. D. V., Maarouf, C. L., Kalback, W. M., Hunter, J. M., Daugs, I. D., Luehrs, D. C., Lopez, J. C., Brune, D. C., Sue, L. I., et al. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.07.004 · Cited by 60
Brown, L. A. M., Jin, J., Ferrell, D., Sadic, E., Obregon, D. F., Smith, A. J., Tan, J., & Giunta, B. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095500 · Cited by 59
Self-citationPeripheral inflammatory biomarkers of Alzheimer’s disease: the role of platelets
Casoli, T., Stefano, G. D., Balietti, M., Solazzi, M., Giorgetti, B., & Fattoretti, P. (2010) · Biogerontology · doi:10.1007/s10522-010-9281-8 · Cited by 59
Timoshanko, J. R., Holdsworth, S. R., Kitching, A. R., & Tipping, P. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.4135 · Cited by 58
Daulatzai, M. A. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9407-2 · Cited by 56
Tanskanen, M., Lindsberg, P. J., Tienari, P. J., Polvikoski, T. M., Sulkava, R. O., Verkkoniemi, A., Rastas, S., Paetau, A. E., & Kiuru‐Enari, S. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00652.x · Cited by 57
Brain Edema After Human Cerebral Hemorrhage A Magnetic Resonance Imaging Volumetric Analysis
Carhuapoma, J. R., Hanley, D. F., Banerjee, M., & Beauchamp, N. J. (2003) · Journal of Neurosurgical Anesthesiology · doi:10.1097/00008506-200307000-00010 · Cited by 54
Rapidly reversible dementia in cerebral amyloid inflammatory vasculopathy
Harkness, K. A., Coles, A. J., Pohl, U., Xuereb, J. H., Baron, J., & Lennox, G. G. (2003) · European Journal of Neurology · doi:10.1046/j.1351-5101.2003.00707.x · Cited by 54
Christov, A. M., Ottman, J. T., & Grammas, P. (2004) · Neurological Research · doi:10.1179/016164104225016218 · Cited by 54
Cerebral amyloid angiopathy and related inflammatory disorders
Chwalisz, B. K. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117425 · Cited by 53
Changes in the immune system in depression and dementia: causal or coincidental effects?
Leonard, B. E., & Myint, A.-M. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.2/bleonard · Cited by 52
Impact of the CD40-CD40L Dyad in Alzheimers Disease
Giunta, B. N., Rezai-Zadeh, K. P., & Tan, J. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791012099 · Cited by 50
Self-citationDarlington, D., Deng, J., Giunta, B. N., Hou, H., Sanberg, C. D., Kuzmin‐Nichols, N., Zhou, H., Mori, T., Ehrhart, J. C., Sanberg, P. R., et al. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0345 · Cited by 46
Self-citationGonzalez‐Velasquez, F. J., & Moss, M. A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04988.x · Cited by 43
Yang, D., Yeh, C.-H., Chen, S., Xu, J., & Hsu, C. Y. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.06.001 · Cited by 44
Liu, R., Li, J.-Z., Song, J.-K., Sun, J., Li, Y., Zhou, S., Zhang, T., & Du, G. (2014) · BioMed Research International · doi:10.1155/2014/470393 · Cited by 43
Contribution of blood platelets to vascular pathology in Alzheimer's disease
Zhang, W., Huang, & Fang, J. (2013) · Journal of Blood Medicine · doi:10.2147/jbm.s45071 · Cited by 40
Cerebral amyloid angiopathy: Review of clinico‐radiological features and mimics
Sharma, R., Dearaugo, S., Infeld, B., O’Sullivan, R., & Gerraty, R. P. (2018) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/1754-9485.12726 · Cited by 44
Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion
Pleet, M. L., DeMarino, C., Stonier, S. W., Dye, J. M., Jacobson, S., Aman, M. J., & Kashanchi, F. (2019) · Viruses · doi:10.3390/v11050410 · Cited by 41
Drake, J., Initiative, A. D. N., Chambers, A. B., Ott, B. R., & Daiello, L. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200759 · Cited by 41
Diagnostic utility of APOE, soluble CD40, CD40L, and Aβ1–40 levels in plasma in Alzheimer’s disease
Ait‐Ghezala, G., Abdullah, L. I., Volmar, C., Paris, D., Luis, C. A., Quadros, A., Mouzon, B., Mullan, M. A., Keegan, A. P., Parrish, J., et al. (2008) · Cytokine · doi:10.1016/j.cyto.2008.08.013 · Cited by 39
Self-citationEnhanced soluble CD40 ligand and Alzheimer's disease: Evidence of a possible pathogenetic role
Desideri, G., Cipollone, F., Necozione, S., Marini, C., Lechiara, M. C., Taglieri, G., Zuliani, G., Fellin, R., Mezzetti, A., di Orio, F., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.10.019 · Cited by 38
Li, M., Pisalyaput, K., Galvan, M. D., & Tenner, A. J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02765.x · Cited by 38
Sawmiller, D. R., Habib, A., Hou, H., Mori, T., Fan, A., Tian, J., Jin, Z., Giunta, B. N., Sanberg, P. R., Mattson, M. P., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.04.026 · Cited by 38
Self-citationRetractedInflammatory Cerebral Amyloid Angiopathy: A Broad Clinical Spectrum
de Souza, A., & Tasker, K. (2023) · Journal of Clinical Neurology · doi:10.3988/jcn.2022.0493 · Cited by 38
Cytokine regulation of CD40 expression in fetal human astrocyte cultures
Abdel‐Haq, N., Hao, H., & Lyman, W. D. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00124-1 · Cited by 36
Zhao, L., Hou, L., Sun, H., Yan, X., Sun, X., Li, J., Bian, Y., Chu, Y., & Liu, Q. (2011) · Molecules · doi:10.3390/molecules16054005 · Cited by 33
Salemi, J., Obregon, D. F., Cobb, A., Reed, S., Sadic, E., Jin, J., Fernandez, F., Tan, J., & Giunta, B. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-3 · Cited by 28
Self-citationUnzeta, M., Hernández‐Guillamón, M., Sun, P., & Solé, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073365 · Cited by 34
Glycation: The angiogenic paradox in aging and age-related disorders and diseases
Roca, F., Grossin, N., Chassagne, P., Puisieux, F. L., & Boulanger, É. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.03.009 · Cited by 35
EVALUATION OF HOW CIGARETTE SMOKE IS A DIRECT RISK FACTOR FOR ALZHEIMER'S DISEASE
Giunta, B. N., Deng, J., Jin, J., Sadic, E., Rum, S., Zhou, H., Sanberg, P. R., & Tan, J. (2012) · Technology & Innovation · doi:10.3727/194982412x13378627621752 · Cited by 30
Self-citationBlaise, R., Mateo, V., Rouxel, C., Zaccarini, F., Glorian, M., Bereziat, G., Golubkov, V. S., & Limon, I. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00797.x · Cited by 30
Alzheimer's disease, inflammation and non-steroidal anti-inflammatory drugs
Ferencĭk, M., Novák, M., Rovensky, J., & Rybár, I. (2001) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03656411 · Cited by 29
Yu, H., Li, X.-Y., Zhou, X. J., Yuan, L., Ma, W., Xi, Y., Zhao, X., Wu, J., & Xiao, R. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0063-z · Cited by 25
Rajagopalan, L. E., & Malter, J. S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740052.x · Cited by 24
H2S releasing aspirin protects amyloid beta induced cell toxicity in BV-2 microglial cells
Liu, Y.-Y., Sparatore, A., Soldato, P. D., & Bian, J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.023 · Cited by 22
Apelt, J., Leßig, J., & Schliebs, R. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00589-x · Cited by 21
Vromman, A., Trabelsi, N., Rouxel, C., Bereziat, G., Limon, I., & Blaise, R. (2013) · Aging Cell · doi:10.1111/acel.12056 · Cited by 20
Therapeutic Effects of Curcumin on Alzheimer’s Disease
Yao, E. C., & Xue, L. (2014) · Advances in Alzheimer s Disease · doi:10.4236/aad.2014.34014 · Cited by 19
Roeben, B., the TREND study team, Maetzler, W., Vanmechelen, E., Schulte, C., Heinzel, S., Stellos, K., Godau, J., Huber, H., Brockmann, K., et al. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150575 · Cited by 19
Sasahara, T., Satomura, K., Tada, M., Kakita, A., & Hoshi, M. M. (2021) · iScience · doi:10.1016/j.isci.2021.102936 · Cited by 17
Is Alzheimer disease a failure of mobilizing immune defense? Lessons from cognitively fit oldest-old
Katsel, P., & Haroutunian, V. H. (2019) · Phlebolymphology · doi:10.31887/dcns.2019.21.1/vharoutunian · Cited by 14
Soluble CD40 ligand in dementia
Giunta, B. N., Figueroa, K. P., Town, T., & Tan, J. (2009) · Drugs of the Future · doi:10.1358/dof.2009.034.04.1358595 · Cited by 14
Self-citationHossen, F., Geng, X. H., Sun, G. Y., Yao, X., & Lee, J. C. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04138-z · Cited by 13
Fujiwara, Y., Takahashi, M., Tanaka, M., Hoshi, T., Someya, T., & Shinkai, S. (2003) · Gerontology · doi:10.1159/000073765 · Cited by 11
Guillemin, G. J., & Brew, B. J. (2007) · International Congress Series · doi:10.1016/j.ics.2007.07.031 · Cited by 9
Lin, X., Bai, G., Lin, L., Wu, H., Cai, J., Ugen, K. E., & Cao, C. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28735 · Cited by 9
Volmar, C., Ait‐Ghezala, G., Frieling, J. S., Weeks, O. I., & MULLAN, M. J. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.04.023 · Cited by 8
Self-citationAhuja, M., Patel, M., Majrashi, M., Mulabagal, V., & Dhanasekaran, M. (2017) · Medicinal and aromatic plants of the world · doi:10.1007/978-981-10-5978-0_1 · Cited by 9
Amyloid Beta and Cardiovascular Disease
Williams, B. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.01.013 · Cited by 8
Kou, J., Kim, H. D., Jin, J., Cao, D., Li, L., Lalonde, R., & Fukuchi, K. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.102 · Cited by 8
A graph theoretic mathematical model for Alzheimer's disease: Using a systems biology approach
Kyrtsos, C. R., & Baras, J. S. (2012) · IEEE International Conference on Bioinformatics and Bioengineering (BIBE) · doi:10.1109/bibe.2012.6399723 · Cited by 7
Zhao, J., Zhao, D. B., Wang, J., Luo, X., & Guo, R. (2022) · European Journal of Inflammation · doi:10.1177/1721727x221095383 · Cited by 6
Effects of Amyloid Beta Peptide on Neurovascular Cells
Askarova, S., Tsoy, A., Shalakhmetova, T. M., & Lee, J. C. (2013) · Central Asian Journal of Global Health · doi:10.5195/cajgh.2012.4 · Cited by 5
Reactive Oxygen Species and Cerebrovascular Diseases
Miller, A. A., Silva, T. M. D., Drummond, G. R., Sobey, C. G., & Chrissobolis, S. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_78 · Cited by 3
Campos, J. (2013) · Journal of Antivirals & Antiretrovirals · doi:10.4172/jaa.s10-003 · Cited by 3
Metadata
- Authors
- Suo, Z., Tan, J., Placzek, A., Crawford, F., Fang, C., & Mullan, M.
- Affiliations
- University of South Florida (US)
- Corresponding author
- Suo, Zhiming
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 1998-10
- Volume
- 807
- Issue
- 1-2
- Pages
- 110-117
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2052556375
- Cited by
- 116
- References
- 43
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 5 · 2019: 4 · 2018: 2 · 2017: 2 · 2016: 2 · 2015: 2 · 2014: 9 · 2013: 9 · 2012: 6
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- Alzheimer's disease, amyloid-beta, cerebral amyloid angiopathy, vascular inflammation, CD40, CD40 ligand, interferon-gamma, IL-1β, interferon-gamma receptor, endothelial cells, vascular smooth muscle cells, adhesion molecules, amyloid-beta 42, Aβ40, cytokine synergy
- MeSH terms
- Interferon gamma Receptor, Alzheimer Disease, Cell Line, Endothelium, Vascular, Humans, Inflammation, Interferon-gamma, Interleukin-1, Muscle, Smooth, Vascular, Signal Transduction, Up-Regulation, Cytokines, Amyloid beta-Peptides, Receptors, Interferon, Intercellular Adhesion Molecule-1, CD40 Antigens, E-Selectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review